Home > National Drug Code (NDC) > Bisoprolol Fumarate and Hydrochlorothiazide

Bisoprolol Fumarate and Hydrochlorothiazide - 0185-0704-30 - (Bisoprolol Fumarate and Hydrochlorothiazide)

Alphabetical Index


Drug Information of Bisoprolol Fumarate and Hydrochlorothiazide

Product NDC: 0185-0704
Proprietary Name: Bisoprolol Fumarate and Hydrochlorothiazide
Non Proprietary Name: Bisoprolol Fumarate and Hydrochlorothiazide
Active Ingredient(s): 5; 6.25    mg/1; mg/1 & nbsp;   Bisoprolol Fumarate and Hydrochlorothiazide
Administration Route(s): ORAL
Dosage Form(s): TABLET, COATED
Coding System: National Drug Codes(NDC)

Labeler Information of Bisoprolol Fumarate and Hydrochlorothiazide

Product NDC: 0185-0704
Labeler Name: Eon Labs, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA075579
Marketing Category: ANDA
Start Marketing Date: 20000925

Package Information of Bisoprolol Fumarate and Hydrochlorothiazide

Package NDC: 0185-0704-30
Package Description: 30 TABLET, COATED in 1 BOTTLE (0185-0704-30)

NDC Information of Bisoprolol Fumarate and Hydrochlorothiazide

NDC Code 0185-0704-30
Proprietary Name Bisoprolol Fumarate and Hydrochlorothiazide
Package Description 30 TABLET, COATED in 1 BOTTLE (0185-0704-30)
Product NDC 0185-0704
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Bisoprolol Fumarate and Hydrochlorothiazide
Dosage Form Name TABLET, COATED
Route Name ORAL
Start Marketing Date 20000925
Marketing Category Name ANDA
Labeler Name Eon Labs, Inc.
Substance Name BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
Strength Number 5; 6.25
Strength Unit mg/1; mg/1
Pharmaceutical Classes Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]

Complete Information of Bisoprolol Fumarate and Hydrochlorothiazide


General Information